NAT2 Polymorphisms with Oral Carcinoma Susceptibility: a Meta-analysis

Overview

Journal Mol Biol Rep

Specialty Molecular Biology

Date 2012 Jun 23

PMID 22722991

Citations 3

Authors

Xian-Lu Zhuo

Jun-Jun Ling

Yan Zhou

Hou-Yu Zhao

Yu-Feng Song

Ying-Hui Tan

Affiliations

Soon will be listed here.

Abstract

Published data have implicated NAT2 polymorphisms as risk factors for various cancers. A number of studies have focused on the association of NAT2 polymorphisms with susceptibility to oral carcinoma and have yielded inconclusive results. The aim of the present study was to derive a more precise estimation of the relationship. We first carried out a deliberate search in the databases without a language limitation, covering all papers published up to Dec 2011. A total of seven case-control studies including 1,379 cases and 1,868 controls were selected and the relevant data were extracted for systematic meta-analyses. No significant association was found for the overall data (OR: 1.04, 95 % CI: 0.79-1.39). In subgroup analyses according to ethnicity, slow acetylators might increase oral cancer risk among Asians (OR: 1.38, 95 % CI: 1.04-1.82) but not Caucasians or Mixed races. The data suggested that NAT2 polymorphisms might be a low-penetrant risk factor for oral carcinoma in Asians.

Citing Articles

Association of Polymorphisms with Susceptibility to Head and Neck Cancers-A Meta-Analysis, Meta-Regression, and Trial Sequential Analysis.

Mohammadi H, Momeni Roochi M, Sadeghi M, Garajei A, Heidar H, Ghaderi B Medicina (Kaunas). 2021; 57(10).

PMID: 34684132 PMC: 8541135. DOI: 10.3390/medicina57101095.

Type 2 diabetes mellitus and risk of head and neck cancer subtypes: a systematic review and meta-analysis of observational studies.

Yan P, Wang Y, Yu X, Liu Y, Zhang Z Acta Diabetol. 2021; 58(5):549-565.

PMID: 33389127 DOI: 10.1007/s00592-020-01643-0.

N-acetyltransferase 2 genetic variants confer the susceptibility to head and neck carcinoma: evidence from 23 case-control studies.

Zhang L, Xiang Z, Hao R, Li R, Zhu Y Tumour Biol. 2013; 35(4):3585-95.

PMID: 24338712 DOI: 10.1007/s13277-013-1473-9.

References

Brockton N, Little J, Sharp L, Cotton S . N-acetyltransferase polymorphisms and colorectal cancer: a HuGE review. Am J Epidemiol. 2000; 151(9):846-61. DOI: 10.1093/oxfordjournals.aje.a010289. View

Klaunig J, Kamendulis L, Hocevar B . Oxidative stress and oxidative damage in carcinogenesis. Toxicol Pathol. 2009; 38(1):96-109. DOI: 10.1177/0192623309356453. View

Boffetta P . Biomarkers in cancer epidemiology: an integrative approach. Carcinogenesis. 2009; 31(1):121-6. DOI: 10.1093/carcin/bgp269. View

Moore L, Baris D, Figueroa J, Garcia-Closas M, Karagas M, Schwenn M . GSTM1 null and NAT2 slow acetylation genotypes, smoking intensity and bladder cancer risk: results from the New England bladder cancer study and NAT2 meta-analysis. Carcinogenesis. 2010; 32(2):182-9. PMC: 3026839. DOI: 10.1093/carcin/bgq223. View

Balaji L, Singh Krishna B, Bhaskar L . An unlikely role for the NAT2 genotypes and haplotypes in the oral cancer of south Indians. Arch Oral Biol. 2011; 57(5):513-8. DOI: 10.1016/j.archoralbio.2011.10.019. View

Zhang J, Qiu L, Wang Z, Wang J, He S, Hu X . NAT2 polymorphisms combining with smoking associated with breast cancer susceptibility: a meta-analysis. Breast Cancer Res Treat. 2010; 123(3):877-83. DOI: 10.1007/s10549-010-0807-1. View

Chen C, Ricks S, Doody D, Fitzgibbons E, Porter P, Schwartz S . N-Acetyltransferase 2 polymorphisms, cigarette smoking and alcohol consumption, and oral squamous cell cancer risk. Carcinogenesis. 2001; 22(12):1993-9. DOI: 10.1093/carcin/22.12.1993. View

Morita S, Yano M, Tsujinaka T, Akiyama Y, Taniguchi M, Kaneko K . Genetic polymorphisms of drug-metabolizing enzymes and susceptibility to head-and-neck squamous-cell carcinoma. Int J Cancer. 1999; 80(5):685-8. DOI: 10.1002/(sici)1097-0215(19990301)80:5<685::aid-ijc9>3.0.co;2-w. View

Cui D, Wang Z, Zhao E, Ma J, Lu W . NAT2 polymorphism and lung cancer risk: a meta-analysis. Lung Cancer. 2011; 73(2):153-7. DOI: 10.1016/j.lungcan.2010.12.012. View

10.

Katoh T, Kaneko S, BOISSY R, Watson M, Ikemura K, Bell D . A pilot study testing the association between N-acetyltransferases 1 and 2 and risk of oral squamous cell carcinoma in Japanese people. Carcinogenesis. 1998; 19(10):1803-7. DOI: 10.1093/carcin/19.10.1803. View

11.

Hou Y, Ou H, Chu S, Wu P, Lu P, Chi C . NAT2 slow acetylation haplotypes are associated with the increased risk of betel quid-related oral and pharyngeal squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011; 112(4):484-92. DOI: 10.1016/j.tripleo.2011.03.036. View

12.

Sabbagh A, Darlu P, Crouau-Roy B, Poloni E . Arylamine N-acetyltransferase 2 (NAT2) genetic diversity and traditional subsistence: a worldwide population survey. PLoS One. 2011; 6(4):e18507. PMC: 3071824. DOI: 10.1371/journal.pone.0018507. View

13.

Liu L, Wagner C, Hanna P . Isoform-selective inactivation of human arylamine N-acetyltransferases by reactive metabolites of carcinogenic arylamines. Chem Res Toxicol. 2009; 22(12):1962-74. DOI: 10.1021/tx9002676. View

14.

Wikman H, Bouchardy C, Mitrunen K, Dayer P, Benhamou S, Hirvonen A . Role of arylamine N-acetyltransferase 1 and 2 (NAT1 and NAT2) genotypes in susceptibility to oral/pharyngeal and laryngeal cancers. Pharmacogenetics. 2000; 9(4):533-7. View

15.

Gong C, Hu X, Gao Y, Cao Y, Gao F, Mo Z . A meta-analysis of the NAT1 and NAT2 polymorphisms and prostate cancer: a huge review. Med Oncol. 2010; 28(1):365-76. DOI: 10.1007/s12032-010-9423-5. View

16.

Zygogianni A, Kyrgias G, Karakitsos P, Psyrri A, Kouvaris J, Kelekis N . Oral squamous cell cancer: early detection and the role of alcohol and smoking. Head Neck Oncol. 2011; 3:2. PMC: 3022893. DOI: 10.1186/1758-3284-3-2. View

17.

Garcia-Martin E . Interethnic and intraethnic variability of NAT2 single nucleotide polymorphisms. Curr Drug Metab. 2008; 9(6):487-97. DOI: 10.2174/138920008784892155. View

18.

Ochs-Balcom H, Wiesner G, Elston R . A meta-analysis of the association of N-acetyltransferase 2 gene (NAT2) variants with breast cancer. Am J Epidemiol. 2007; 166(3):246-54. DOI: 10.1093/aje/kwm066. View

19.

Ying X, Dong P, Shen B, Wang J, Wang S, Wang G . Possible association of NAT2 polymorphism with laryngeal cancer risk: an evidence-based meta-analysis. J Cancer Res Clin Oncol. 2011; 137(11):1661-7. DOI: 10.1007/s00432-011-1045-6. View

20.

Reichart P, Nguyen X . Betel quid chewing, oral cancer and other oral mucosal diseases in Vietnam: a review. J Oral Pathol Med. 2008; 37(9):511-4. DOI: 10.1111/j.1600-0714.2008.00669.x. View